CompletedPhase 4Other

Opioid Free Anesthesia and Bariatric Surgery

NCT ID

NCT04144153

Target Enrollment

58 participants

Start Date

2021-08-09

Est. Completion

2023-09-01

About This Study

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

Conditions Studied

Postoperative Quality of Recovery

Interventions

•Opioid Free Total Intravenous Anesthesia
•Total Intravenous anesthesia with opioid

Eligibility

Age:18 Years - 70 Years

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* ASA I-III
* Non-pregnant
* Undergoing laparoscopic bariatric surgery for weight loss.

Exclusion Criteria:

* Unable to obtain informed consent or consent withdrawn.
* Patients who are pregnant or nursing.
* ASA IV-V
* Alcohol or narcotic misuse or dependence in the last 2 years.
* Preoperative daily opioid use for one year for pain management.
* Egg or soy product allergy
* Active liver disease
* Patients with left ventricular assist devices
* Abnormal renal function
* Any contraindication to any opioid or non-opioid pain analgesics
* Any physical, mental or medical condition that in the opinion of the investigator, makes study participation inadvisable.

Study Locations (1)

North Shore University Hospital